Image courtesy of DALL-E 3. Prompt: An oil painting of a skeleton riding a black rodeo bull wearing a cowbow hat

Step right up to the X-Ray Rho-deo

Osteoporosis is underdiagnosed and underscreened with only about 22% of the eligible population being screened. 80% of fragility fractures occur in patients who have never been screened. The result is preventable fractures and a $4 billion economic burden in Canada. Luckily, about 80% of patients who have not been screened with DXA have had an x-ray for some other reason. These x-rays can be used by Rho™ to flag which patients are at risk of low bone mineral density (BMD).

Rho is a patent-pending Health Canada approved software medical device (SaMD) developed by 16 Bit to function as an opportunistic screen for low BMD (T-Score < -1 on DXA) in patients 50 years and older. It uses frontal x-rays of the chest, thoracic spine, lumbar spine, pelvis, knee or hand to output a Rho Score between 1-10 which correlates with the patient's risk of having low BMD on DXA. Rho leverages acquired x-rays to derive actionable insights about a patient's bone health so that diagnosis and therapy can occur earlier.

This demonstration will present you with 16 randomly selected cases from our test set of over 7,000 x-rays with ground-truth established by DXA performed within 1 year of the x-ray. You will receive your score compared to Rho after you submit your responses. The purpose is to highlight the diagnostic challenge of detecting low BMD on x-ray and how Rho can assist radiologists and healthcare professionals to play a central role in screening their population.

Username

Full Name

Email

Institution

I agree to the rules and regulations of the contest and to be signed up to 16 Bit's mailing list.

Submit